FHC
INO icon

First Horizon Corporation’s Inovio Pharmaceuticals INO Stock Holding History

First Horizon Corporation’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$9K Hold
83
– – ﹤0.01% 719
2021
Q1 		$9K Hold
83
– – ﹤0.01% 706
2020
Q4 		$8K Hold
83
– – ﹤0.01% 696
2020
Q3 		$11K Buy
+83
New +$17.3K ﹤0.01% 597

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Horizon Corporation's INO Position: Q2 2021 in Review

First Horizon Corporation held its Inovio Pharmaceuticals (INO) position steady in Q2 2021 at 83 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

First Horizon Corporation first reported a position in INO in Q3 2020 and has held it in 4 quarters since. The position peaked at $11K in Q3 2020. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • First Horizon Corporation held 83 shares of Inovio Pharmaceuticals worth $9K as of Q2 2021.
  • First Horizon Corporation left its Inovio Pharmaceuticals share count unchanged in Q2 2021.
  • Inovio Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #719 holding.
  • First Horizon Corporation first reported a position in Inovio Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
  • First Horizon Corporation's Inovio Pharmaceuticals position peaked at $11K in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.